Crossmark

NMR-based metabolomics identifies patients at high risk of death within two years after acute myocardial infarction in the AMI-Florence II cohort

Crossref DOI link: https://doi.org/10.1186/s12916-018-1240-2

Published Online: 2019-01-07

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Vignoli, Alessia

Tenori, Leonardo

Giusti, Betti http://orcid.org/0000-0002-8708-9444
Takis, Panteleimon G.

Valente, Serafina

Carrabba, Nazario

Balzi, Daniela

Barchielli, Alessandro

Marchionni, Niccolò

Gensini, Gian Franco

Marcucci, Rossella

Luchinat, Claudio

Gori, Anna Maria
Funding

Funding for this research was provided by:

Regione Toscana

Horizon 2020 (634821, 654241)
License Information

Text and Data Mining valid from 2019-01-07
More Information

Article History

Received: 27 December 2017

Accepted: 14 December 2018

First Online: 7 January 2019

Ethics approval and consent to participate

: All subjects gave written informed consent. The study (number 11/2008) complies with the Declaration of Helsinki and was approved by the ethics committees of the local health unit, the University of Florence, and Careggi Hospital (19 March 2008).

: Not applicable

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.